Means Appointed Deputy Director of CCC
Tony Means, PhD, Nanaline H. Duke Professor and chairman of the Department of Pharmacology and Cancer Biology, has been appointed to the position of deputy director of the Comprehensive Cancer Center. More...
 
McDonnell as CCC's Associate Director of Basic Research
As a new member of the Comprehensive Cancer Center's leadership team, Dr. Donald McDonnell assumes the role of Associate Director of Basic Research. More...
 
Congratulations!
Dr. Daniel Lew has been elected Fellow of the American Academy of Microbiology, Class of 2008. More...

More News


Duke’s Pharmacology and Cancer Biology is unique among US basic biomedical science departments as it encompasses two broad and overlapping disciplines. Our 24 faculty members are remarkably diverse and use all of the tools available to biomedical scientists to address questions critical to fundamental biology and human health. The faculty members share the common goal of exploiting cellular signaling pathways to address a myriad of important scientific questions relevant to cancer, metabolism, nervous system function, drugs of abuse and environmental toxicants. Among Pharmacology departments we are ranked 4th by US News and World Report, 4th by the National Research Council and 5th in NIH funding. It is a privilege to welcome you to our website and we encourage you to learn more about the opportunities in research, training and educational offered by this exciting and dynamic department.